Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease

Clin J Am Soc Nephrol. 2021 Dec;16(12):1775-1778. doi: 10.2215/CJN.13601021. Epub 2021 Dec 1.

Authors

Alberto Ortiz^{1

2}, Beatriz Fernandez-Fernandez^{1

2}

Affiliations

¹ Nephrology Department, Fundación Jimenez Díaz Health Research Institute, Madrid, Spain.
² Department of Medicine, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.

No abstract available

Keywords: albuminuria; atrasentan; diabetic nephropathy; endothelin A receptor antagonists.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Albuminuria
Atrasentan / therapeutic use
Diabetes Mellitus*
Diabetic Nephropathies* / drug therapy
Endothelin A Receptor Antagonists / therapeutic use
Endothelin Receptor Antagonists / therapeutic use
Endothelin-1
Humans
Pyrrolidines

Substances

Atrasentan
Endothelin A Receptor Antagonists
Endothelin Receptor Antagonists
Pyrrolidines
Endothelin-1